Global Testicular Cancer Drugs Market 2014-2018 - WSFA.com Montgomery Alabama news.

Global Testicular Cancer Drugs Market 2014-2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Global Testicular Cancer Drugs Market 2014-2018

http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html

TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of testicular cancer. The Global Testicular Cancer Drugs market has also been witnessing the emergence of combination therapies for the treatment of testicular cancer. However, the presence of alternative testicular cancer treatments could pose a challenge to the growth of this market.

TechNavio's report, the Global Testicular Cancer Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market market in the Americas, and the EMEA and APAC regions; it also covers the Global Testicular Cancer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Bristol-Myers Squibb Co., Hospira Inc., Teva Pharmaceutical Industries Ltd., and ZIOPHARM Oncology Inc.

Other vendors mentioned in the report are Baxter International Inc., Fresenius Kabi Pharmaceuticals Holding Inc., and Mylan Pharmaceutical Inc.

Key questions answered in this report:

What will the market size be in 2016/2018 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Testicular Cancer by Type
07.1.1 Seminoma
07.1.2 Non-seminoma
08. Testicular Cancer Disease by Stages
08.1.1 Stage 0
08.1.2 Stage I
08.1.3 Stage II
08.1.4 Stage III
09. Treatment Options
09.1 Surgery
09.2 Radiation Therapy
09.3 Chemotherapy
10. Clinical Trial Snapshot
11. Geographical Segmentation
11.1 Global Testicular Cancer Drugs Market by Geographical Segmentation
12. Buying Criteria
13. Rate of Incidence and Prevalence
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Acquisitions
20.2 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Bristol-Myers Squibb Co.
21.1.1 Business Overview
21.1.2 Key Information
21.1.3 SWOT Analysis
21.2 Hospira Inc.
21.2.1 Business Overview
21.2.2 Business Segmentation
21.2.3 Key Information
21.2.4 SWOT Analysis
21.3 Teva Pharmaceutical Industries Ltd.
21.3.1 Business Overview
21.3.2 Business Segmentation
21.3.3 Key Information
21.3.4 SWOT Analysis
21.4 ZIOPHARM Oncology Inc.
21.4.1 Business Overview
21.4.2 Key Information
21.4.3 SWOT Analysis
22. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Testicular Cancer Drugs market 2013-2018 (US$ million)
Exhibit 3: Testicular Cancer Segmentation by Type
Exhibit 4: Global Testicular Cancer Drugs Market by Geographical Segmentation 2013 (percent)
Exhibit 5: Business Segmentation of Hospira Inc.
Exhibit 6: Business Segmentation of Teva Pharmaceutical Industries Ltd.

Companies Mentioned

Bristol-Myers Squibb Co., Hospira Inc., Teva Pharmaceutical Industries Ltd., and ZIOPHARM Oncology Inc.

Read the full report:
Global Testicular Cancer Drugs Market 2014-2018

http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow